Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever

Mise à jour : Il y a 4 ans
Référence : NCT01601613

Femme et Homme

Extrait

This trial is conducted in Asia. The aim of this is to investigate the efficacy and safety of activated recombinant human factor VII (rFVIIa) in achieving haemostasis in patients with Dengue haemorrhagic fever (DHF).


Critère d'inclusion

  • Acquired Bleeding Disorder ,Dengue Haemorrhagic Fever

Liens